Bausch Health Companies Inc.

BHC
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0000885590

Price chart

Open-market purchases and sales by BHC insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Aug 20, 20264:33 PM ETAug 19, 2026Lenar Aimee J.President, US PharmaSSaleCommon Shares, No Par Value−36.83K$7.03−$258.89K334.85K−9.9%SEC10b5-1
May 20, 2026May 19, 2026Lee Frank D.DirectorSSaleCommon Shares, No Par Value−24.46K$5.43−$132.8K49.34K−33.1%SEC10b5-1
Mar 3, 2026Mar 2 – Mar 3, 2026Carson SeanaEVP, General CounselSSaleCommon Shares, No Par Value−11.28K$5.7761−$65.13K616.76K−1.8%SEC10b5-1
Feb 27, 2026Feb 27, 2026Carson SeanaEVP, General CounselSSaleCommon Shares, No Par Value−8.39K$5.95−$49.91K809.26K−1.0%SEC10b5-1
Nov 28, 2025Nov 25, 2025PAULSON & CO. INC.10% OwnerPPurchaseCommon Stock, no par value+2.5M$6.25+$15.63M73.26M+3.5%SEC

The largest institutional positions in BHC at the end of Q2 2026.

Institutions holding BHC in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
PAULSON & CO. INC.73,255,869$361.15M14.02%00.0%Unchanged
GOLDENTREE ASSET MANAGEMENT LP34,665,731$170.71M9.92%00.0%Unchanged
ROYAL BANK OF CANADA10,832,582$53.4M0.01%−530,916−4.7%Reduced
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND8,000,000$39.44M0.06%00.0%Unchanged
VANGUARD CAPITAL MANAGEMENT LLC7,465,468$36.8M0.00%+61,709+0.8%Added